Effect of favipiravir and an anti-inflammatory strategy for COVID-19

Detalles Bibliográficos
Autores principales: Yamamura, Hitoshi, Matsuura, Hiroshi, Nakagawa, Junichiro, Fukuoka, Hiroshi, Domi, Hisaya, Chujoh, Satoru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347251/
https://www.ncbi.nlm.nih.gov/pubmed/32646499
http://dx.doi.org/10.1186/s13054-020-03137-5
_version_ 1783556557718421504
author Yamamura, Hitoshi
Matsuura, Hiroshi
Nakagawa, Junichiro
Fukuoka, Hiroshi
Domi, Hisaya
Chujoh, Satoru
author_facet Yamamura, Hitoshi
Matsuura, Hiroshi
Nakagawa, Junichiro
Fukuoka, Hiroshi
Domi, Hisaya
Chujoh, Satoru
author_sort Yamamura, Hitoshi
collection PubMed
description
format Online
Article
Text
id pubmed-7347251
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-73472512020-07-10 Effect of favipiravir and an anti-inflammatory strategy for COVID-19 Yamamura, Hitoshi Matsuura, Hiroshi Nakagawa, Junichiro Fukuoka, Hiroshi Domi, Hisaya Chujoh, Satoru Crit Care Research Letter BioMed Central 2020-07-09 /pmc/articles/PMC7347251/ /pubmed/32646499 http://dx.doi.org/10.1186/s13054-020-03137-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Letter
Yamamura, Hitoshi
Matsuura, Hiroshi
Nakagawa, Junichiro
Fukuoka, Hiroshi
Domi, Hisaya
Chujoh, Satoru
Effect of favipiravir and an anti-inflammatory strategy for COVID-19
title Effect of favipiravir and an anti-inflammatory strategy for COVID-19
title_full Effect of favipiravir and an anti-inflammatory strategy for COVID-19
title_fullStr Effect of favipiravir and an anti-inflammatory strategy for COVID-19
title_full_unstemmed Effect of favipiravir and an anti-inflammatory strategy for COVID-19
title_short Effect of favipiravir and an anti-inflammatory strategy for COVID-19
title_sort effect of favipiravir and an anti-inflammatory strategy for covid-19
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347251/
https://www.ncbi.nlm.nih.gov/pubmed/32646499
http://dx.doi.org/10.1186/s13054-020-03137-5
work_keys_str_mv AT yamamurahitoshi effectoffavipiravirandanantiinflammatorystrategyforcovid19
AT matsuurahiroshi effectoffavipiravirandanantiinflammatorystrategyforcovid19
AT nakagawajunichiro effectoffavipiravirandanantiinflammatorystrategyforcovid19
AT fukuokahiroshi effectoffavipiravirandanantiinflammatorystrategyforcovid19
AT domihisaya effectoffavipiravirandanantiinflammatorystrategyforcovid19
AT chujohsatoru effectoffavipiravirandanantiinflammatorystrategyforcovid19

Ejemplares similares